Foundation Medicine at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Foundation Medicine exhibits at Booth 16 at ISLB 2026 in Madrid, and takes part in 1 session. Its work centres on ultra-sensitive detection of minimal residual disease. It covers the science behind FoundationOne MRD and its push below current sensitivity limits.

OrganizationISLB 2026 Attendance
◇Bronze Sponsor
Diagnostics & testing labsBronze Sponsor
Genomic profiling company offering tissue and blood cancer tests and companion diagnostics to guide treatment and support drug research; part of Roche.
Booth
Exhibiting at Booth 16
Sat, Nov 710:00am–4:00pm, 6:00–7:30pmSun, Nov 810:00am–4:00pmMon, Nov 98:30am–10:30am
Industry
Sat Nov 7
11:20am–11:40am
FoundationOne MRD: Breaking the Sensitivity Floor: The Science of Ultra-sensitive MRD
ctDNA & MRD

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Foundation Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction